In the case of patients with autoimmune diseases, treatments are based on drugs such as anti-TNF agents and interleukin-6 receptor blockers, thus favoring the onset of infections by blocking the signal transduction from the cell surface receptors to the nucleus [63]. This evidence concerns the gene CD177 and infection.